Sartorius-Stedim Biotech S.A. (SW)

Sartorius Stedim Biotech, headquartered in Aubagne, France, is a global leader in providing technologies and services for the development and manufacturing of biopharmaceutical products. Led by CEO René Fáber, the company’s strategy is "The Bioprocessing Specialist"—focusing on single-use technologies and automated solutions for cell and gene therapy and vaccine production. Its core strategy centers on its "Total Solution Provider" approach, from cell line development to final product fill-and-finish. Sartorius’ mission is to help scientists and engineers develop and manufacture medicines faster and more efficiently. The company is currently a primary beneficiary of the "GLP-1 and Biologic Boom," leveraging its indispensable role in the drug manufacturing supply chain to drive long-term, high-margin growth.